39 related articles for article (PubMed ID: 12649770)
1. Second-generation antipsychotics and VTE risk.
DeLoughery EP
Eur J Haematol; 2024 Apr; ():. PubMed ID: 38644355
[No Abstract] [Full Text] [Related]
2. The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.
Sonntag M; König HH; Konnopka A
Pharmacoeconomics; 2013 Dec; 31(12):1131-54. PubMed ID: 24293216
[TBL] [Abstract][Full Text] [Related]
3. Emerging empirical evidence on the ethics of schizophrenia research.
Dunn LB; Candilis PJ; Roberts LW
Schizophr Bull; 2006 Jan; 32(1):47-68. PubMed ID: 16237201
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
5. [New antipsychotics in the treatment of schizophrenia. A European survey].
Sarfati Y; Olivier V; Bouhassira M
Encephale; 1999; 25(6):658-66. PubMed ID: 10668612
[TBL] [Abstract][Full Text] [Related]
6. Are the second-generation antipsychotics cost-effective? A critical review on the background of different health systems.
Hamann J; Leucht S; Kissling W
Pharmacopsychiatry; 2003 Jan; 36(1):18-26. PubMed ID: 12649770
[TBL] [Abstract][Full Text] [Related]
7. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
Neumann PJ
J Clin Psychiatry; 1999; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.
Obradovic M; Mrhar A; Kos M
Int J Clin Pract; 2007 Dec; 61(12):1979-88. PubMed ID: 17997804
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacoeconomic review of the use of injectable long-acting risperidone].
Bartkó G; Fehér L
Neuropsychopharmacol Hung; 2005 Dec; 7(4):199-207. PubMed ID: 16496485
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]